Maniraj Bhagawati1, Tobias M E Terhorst1, Friederike Füsser1, Simon Hoffmann1, Tim Pasch1, Shmuel Pietrokovski2, Henning D Mootz3. 1. Institute of Biochemistry, University of Münster, 48149 Münster, Germany. 2. Department of Molecular Genetics, Weizmann Institute of Science, 76100 Rehovot, Israel shmuel.pietrokovski@weizmann.ac.il Henning.Mootz@uni-muenster.de. 3. Institute of Biochemistry, University of Münster, 48149 Münster, Germany; shmuel.pietrokovski@weizmann.ac.il Henning.Mootz@uni-muenster.de.
Abstract
Split intein-mediated protein trans-splicing has found extensive applications in chemical biology, protein chemistry, and biotechnology. However, an enduring limitation of all well-established split inteins has been the requirement to carry out the reaction in a reducing environment due to the presence of 1 or 2 catalytic cysteines that need to be in a reduced state for splicing to occur. The concomitant exposure of the fused proteins to reducing agents severely limits the scope of protein trans-splicing by excluding proteins sensitive to reducing conditions, such as those containing critical disulfide bonds. Here we report the discovery, characterization, and engineering of a completely cysteine-less split intein (CL intein) that is capable of efficient trans-splicing at ambient temperatures, without a denaturation step, and in the absence of reducing agents. We demonstrate its utility for the site-specific chemical modification of nanobodies and an antibody Fc fragment by N- and C-terminal trans-splicing with short peptide tags (CysTag) that consist of only a few amino acids and have been prelabeled on a single cysteine using classical cysteine bioconjugation. We also synthesized the short N-terminal fragment of the atypically split CL intein by solid-phase peptide synthesis. Furthermore, using the CL intein in combination with a nanobody-epitope pair as a high-affinity mediator, we showed chemical labeling of the extracellular domain of a cell surface receptor on living mammalian cells with a short CysTag containing a synthetic fluorophore. The CL intein thus greatly expands the scope of applications for protein trans-splicing.
Split intein-mediated protein trans-splicing has found extensive applications in chemical biology, protein chemistry, and biotechnology. However, an enduring limitation of all well-established split inteins has been the requirement to carry out the reaction in a reducing environment due to the presence of 1 or 2 catalytic cysteines that need to be in a reduced state for splicing to occur. The concomitant exposure of the fused proteins to reducing agents severely limits the scope of protein trans-splicing by excluding proteins sensitive to reducing conditions, such as those containing critical n class="Chemical">disulfide bonds. Here we report the discovery, characterization, and engineering of a completely cysteine-less split intein (CL intein) that is capable of efficient trans-splicing at ambient temperatures, without a denaturation step, and in the absence of reducing agents. We demonstrate its utility for the site-specific chemical modification of nanobodies and an antibody Fc fragment by N- and C-terminal trans-splicing with short peptide tags (CysTag) that consist of only a few amino acids and have been prelabeled on a single cysteine using classical cysteine bioconjugation. We also synthesized the short N-terminal fragment of the atypically split CL intein by solid-phase peptide synthesis. Furthermore, using the CL intein in combination with a nanobody-epitope pair as a high-affinity mediator, we showed chemical labeling of the extracellular domain of a cell surface receptor on living mammalian cells with a short CysTag containing a synthetic fluorophore. The CL intein thus greatly expands the scope of applications for protein trans-splicing.
Entities:
Keywords:
chemical biology; fluorescent labeling; protein ligation; thiol bioconjugation
Authors: Christoph Thomas; Ignacio Moraga; Doron Levin; Peter O Krutzik; Yulia Podoplelova; Angelica Trejo; Choongho Lee; Ganit Yarden; Susan E Vleck; Jeffrey S Glenn; Garry P Nolan; Jacob Piehler; Gideon Schreiber; K Christopher Garcia Journal: Cell Date: 2011-08-19 Impact factor: 41.582
Authors: Jenny Ibach; Yvonne Radon; Márton Gelléri; Michael H Sonntag; Luc Brunsveld; Philippe I H Bastiaens; Peter J Verveer Journal: PLoS One Date: 2015-11-17 Impact factor: 3.240
Authors: Vedud Purde; Elena Kudryashova; David B Heisler; Reena Shakya; Dmitri S Kudryashov Journal: Proc Natl Acad Sci U S A Date: 2020-08-24 Impact factor: 11.205
Authors: K K Khoo; I Galleano; F Gasparri; R Wieneke; H Harms; M H Poulsen; H C Chua; M Wulf; R Tampé; S A Pless Journal: Nat Commun Date: 2020-05-08 Impact factor: 14.919
Authors: Maniraj Bhagawati; Simon Hoffmann; Katharina S Höffgen; Jacob Piehler; Karin B Busch; Henning D Mootz Journal: Angew Chem Int Ed Engl Date: 2020-09-11 Impact factor: 15.336